Anusha MD
@md_anusha
Followers
551
Following
3K
Media
58
Statuses
753
Wife, Mom, Heme-Onc fellow @KUcancercenter, @ASCOTECAG, #ASCOTrainee Council, MedEd enthusiast, love heme-onc, Tweets are my own.
Joined March 2020
1/3- Have you ever thought of publishing papers with people you never met?This is the power of Social media. Check out our work on Social Media & Professional Development @JCOOP_ASCO as part of #COSMO. I am blessed to work under the mentorship of @drdonsdizon @DrMarkham @mtmdphd
7
11
73
🚨 Major congratulations! 🚨 Dr. Joseph McGuirk, Division Director of Hematologic Malignancies & Cellular Therapeutics, has been awarded the prestigious 2025 KCU Alumni Lifetime Achievement Award! A true pioneer in CAR T therapy and Malignant Hematology — well deserved! 👏🎉
1
10
54
Starting Now: Radioimmunotherapy and Adjuvant Trials Moderated by: @RamalingamMD @WinshipAtEmory
#DAVALung
0
1
3
Does the time of day affect ICI efficacy? Dr. Sandip Patel @PatelOncology @UCSDHealth reviewed studies showing AM > PM outcomes for anti–PD-(L)1 in NSCLC, while noting practical limits and the need for further data. #DAVALung
2
9
21
As the waves 🌊 settle after #ASCO25 we @DanaFarber_GU take a deeper dive 🤿 into the most impactful data! Join @DrChoueiri @BradMcG04 @AtishChoudhury as we discuss what we learned & where we’re going next! Prostate 🔗 https://t.co/J74lsFlJIQ Bladder 🔗
0
38
76
Honored to moderate the Post-@ASCO 2025 Updates at @KUcancercenter. Great discussions, impactful science, and inspiring colleagues @Oncn @anupkasi @Abdallah81MD @NausheenAhmedMD @AYACOUB7
Excellent discussion. Audience questions mostly future of #CART, where will it be used in next decade and scope with non cancer diseases @KUcancercenter #HemOncReview @Oncn @Abdallah81MD @md_anusha @AYACOUB7
1
1
12
🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯 Years of grit & belief led us here 🥹 Endless thanks to Exelixis for the trust & Dr. Hecht for leading this global win with me! 🎉 @UPMCHillmanCC
ir.exelixis.com
The Investor Relations website contains information about Exelixis, Inc.'s business for stockholders, potential investors, and financial analysts.
15
39
141
Now @anup_kasi presenting Updates in Hepatobiliary and pancreatic Cancer @ Hematology/Oncoloogy Review @KUcancercenter #MedEd #MedTwitter #سرطان_الدم #المايلوما @OncoAlert
0
7
12
0
6
12
Now Dr. Christine Bestvina from University of Chicago presenting Novel Clinical Advances in lung cancer cancer @ Hematology/Oncoloogy Review @KUcancercenter @USMIRCNEWS @OncoAlert #MedEd #MedTwitter #سرطان_الدم #المايلوما wow Taraltamab (The BiTe for small cell lung cancer!!)
0
5
7
Now pannel discussion @md_anusha @anup_kasi @NausheenAhmedMD @AYACOUB7 and Dr. Bhatt @KUcancercenter #MedEd #MedTwitter @OncoAlert @USMIRCNEWS #سرطان_الدم #المايلوما
0
2
3
Now pannel discussion @md_anusha @lihaoran Dr. Weijing Sun and Dr. Christine Bestivina @KUcancercenter #MedEd #MedTwitter @OncoAlert @USMIRCNEWS #سرطان_الدم #المايلوما
0
5
5
Congratulations to @DrChoueiri on being the recipient of a Doctorate Honoris Causa from The Lebanese University recognizing his outstanding achievements in Oncology.
24
16
251
Congratulations @DrChoueiri! So well-deserved and a true testament to your huge impact on our field 👏👏
Congratulations to @DrChoueiri on being the recipient of a Doctorate Honoris Causa from The Lebanese University recognizing his outstanding achievements in Oncology.
1
11
111
Recognizing Top Oncologists, Top Women Oncologists, and Rising Stars from @ASCO 2025 at Times Square! @SuyogCancer | @PTarantinoMD | @ADesaiMD | @StephenVLiu | @HHorinouchi | @DrChoueiri | @dr_yakupergun | @neerajaiims | @AndreaNecchi | @GillSharlene | @Dr_Oncologista |
3
19
50
Low dose IO! @TataMemorial group presented by the outstanding @VanitaNoronha providing more data to support the use of low dose especially in more resource constrained environments but continues to challenge the doses we use
0
16
59
Catching up on #ASCO25 - terrific discussion by @TiansterZhang @utswcancer on abstracts from #SamerSrourMD @MDAndersonNews, @DrChoueiri @DanaFarberNews, @motzermd @MSKCancerCenter & @VivekNarayanMD @PennCancer. Varied topics all eloquently addressed! Thanks for citing the
0
10
36
😇 Honored to serve as discussant for #ASCO25 oral upper GI abstracts. A powerhouse session with science featured simultaneously in 2 @NEJM papers, 1 @TheLancet , and 1 @JCO_ASCO —field-leading science shaping our GI oncology practice ✨. @UPMCHillmanCC
2
4
51
"The key to success in academia is to surround yourself with people that believe in your cause, are not afraid to fight for equality, & are their true selves." Dr @NarjustFlorezMD on finding peer mentors, life long friends, & creating community #ASCO25 👉 https://t.co/a4x9nlFwD9
0
7
50
Still taking it all in—what an honor to highlight some of the most exciting lung cancer research from #ASCO25! Standing at the @ASCO podium has been a DREAM of mine. I’m so deeply grateful for this moment & for the chance to represent a community that means everything to me. 🤍
In the final Highlights of the Day session at #ASCO25, our Dr. Eric Singhi discussed exciting clinical updates in lung cancer from the CheckMate816, NeoADAURA, IMforte, and DeLLphi-304 studies. @LungOncDoc @ASCO #EndCancer
22
14
148
Congratulations to @lungoncdoc for this presentation. Well deserved! #ASCO25
@yekeduz_emre
@DRBakaloudiMD
@AndreaAnampaG
@ReginaBarCar
@cwspeers
@drenriquegrande
@FunchainMD
@MKnoll_MD
@bavilima
@KrishanJethwa
@ASCO
@cancerassassin1
@ryanhuey
@ReneeSaliby
@MikeSerzanMD
Still taking it all in—what an honor to highlight some of the most exciting lung cancer research from #ASCO25! Standing at the @ASCO podium has been a DREAM of mine. I’m so deeply grateful for this moment & for the chance to represent a community that means everything to me. 🤍
1
4
14